Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

New Peer-Reviewed Study Published in Dermatology and Therapy Adds to Clinical Evidence Showing Nutrafol Hair Growth Nutraceuticals Improve Hair Growth in Women

Nutrafol

News provided by

NUTRAFOL

Jul 15, 2026, 09:04 ET

Share this article

Share toX

Share this article

Share toX

Six-month clinical study, first presented at the World Congress for Hair Research, shows significant increases in linear hair growth rate — a clinically meaningful measure of hair growth that has rarely been studied — further expanding Nutrafol's growing body of published research

NEW YORK, July 15, 2026 /PRNewswire/ -- Nutrafol, the #1 dermatologist-recommended hair growth supplement brand,1 today announced the publication of a new peer-reviewed six-month prospective clinical study in Dermatology and Therapy, further expanding its growing body of scientific evidence supporting the efficacy of its Hair Growth Nutraceuticals. These new results demonstrated statistically significant improvements in hair growth rate, hair count, scalp coverage, and other objective measures of hair health in women. Notably, the study evaluated linear hair growth rate (LHGR) – a technically challenging, high-value endpoint that has been infrequently studied in hair research, measuring how quickly hair grows.

The findings were first presented last month in Seoul, South Korea at the 2026 World Congress for Hair Research (WCHR), one of the largest and most prestigious global scientific meetings for hair and scalp studies, where researchers and clinicians showcase the latest advancements in hair biology and clinical science.

"A 6-Month Prospective, Open-Label, Randomized Study Showing Increased Hair Growth Rate in Women Using Multi-Targeting Hair Growth Nutraceuticals" evaluated 180 women between the ages of 18 and 70 using one of Nutrafol's Hair Growth Nutraceuticals, tailored to their unique life stages - such as menopause and postpartum - and lifestyles. Over the six-month study period, participants demonstrated statistically significant improvements in LHGR, with hair growth rates 19% to 37% faster compared to baseline (p<0.001).

"Measuring linear hair growth rate is rarely done in clinical hair research because the technical demands are significant, you need to have the right type of validated equipment, and many therapies simply don't measure or report it. That's what makes this data stand out - it is the kind of finding that should shift how the field evaluates approaches to assess hair thinning and hair health," said Dr. Raja Sivamani, MD, MS, AP, board-certified dermatologist and principal investigator. "The speed of hair growth is something patients notice and care about deeply, and it's exciting to see a multitargeting nutraceutical approach validated on this dimension alongside the other improvements we've seen."

In addition to faster hair growth, results demonstrated statistically significant increases in anagen (actively growing) hairs across all study groups, while also confirming prior clinical evidence tied to total hair count, terminal hair count, and overall scalp coverage. Participants' self-assessments also reflected improvements consistent with the clinical findings.

"We don't just invest in clinical research - we invest in studying the endpoints that matter most to physicians and consumers, even when they're technically challenging to measure," said Dr. Isabelle Raymond, Senior Vice President of Global Medical and Clinical Affairs at Nutrafol. "This study strengthens the clinical evidence supporting our Hair Growth Nutraceuticals, reinforcing the efficacy of our final formulations in helping women across life stages achieve healthier, faster-growing hair. It also reflects our continued commitment to advancing the science of hair health through meaningful, objective endpoints that help set a higher standard for the category."

For more than a decade, Nutrafol has helped define the hair health category through an unwavering commitment to rigorous clinical research and scientific innovation. Today, the brand has completed 26 clinical studies - including three randomized, placebo-controlled trials - evaluating its formulations across multiple life stages and hair wellness needs. Nutrafol is also the first and only hair growth supplement brand to earn NSF Certified for Sport®, the leading independent, third-party certification for supplement safety and quality. Together, these milestones reinforce Nutrafol's commitment to setting the standard for evidence-based innovation, delivering high-quality products that help millions of people achieve healthier hair from within.

More About the Clinical Study
Hair thinning affects millions of women and can result from a variety of factors, including hormonal changes, nutritional status, aging, postpartum, and lifestyle. Previous research has shown that thinner hair fibers often grow slower, making linear hair growth rate an important measure of hair health. This prospective, six-month clinical study expands upon existing evidence by demonstrating that targeted nutraceutical formulations may help improve both the rate of hair growth and other clinically relevant measures of hair health.

Participants were evaluated at baseline, Day 90, and Day 180 using Canfield HairMetrix® imaging technology to objectively assess linear hair growth rate, hair counts, and scalp coverage. Participants also completed validated self-assessment questionnaires throughout the study.

The research was authored by Rubaina Dang ND, Raja K. Sivamani MD MS AP, Adina Hazan PhD, Isabelle Raymond PhD, and newly published in Dermatology and Therapy. The findings were initially presented as an abstract at the 2026 World Congress for Hair Research in South Korea in May 2026 before undergoing peer review and publication.

For more information about Nutrafol's clinical research, please visit Nutrafol.com/clinical.

About Nutrafol
Nutrafol is the #1 dermatologist recommended hair growth supplement brand, known for its whole-body, evidence-based approach to hair health. Nutrafol's physician-formulated, 100% drug-free supplements are tailored to support hair thinning through different life stages and lifestyles, targeting underlying causes of thinning hair: stress, hormones, lifestyle, metabolism, nutrition, and aging. As the first and only hair growth supplement brand to earn NSF Certified for Sport® - the preeminent, independent third-party certification program - it continues to meet the highest standards in quality and safety, using high-quality ingredients backed by published research. Nutrafol prioritizes clinical rigor, with clinical studies conducted on different populations to support the efficacy of its final formulations and over 20 published studies on hair wellness. Today, Nutrafol has been adopted by 7,500 healthcare providers nationwide, is trusted by over 1.5 million customers, and has earned numerous prestigious accolades. For more information, visit www.nutrafol.com.

Media Contact: [email protected]

1 According to IQVIA ProVoice survey for 12 months ending March 31, 2026.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

SOURCE NUTRAFOL

21%

more press release views with 
Request a Demo

Modal title

Also from this source

Nutrafol Secures Multiple Top Honors from U.S. News & World Report, Including #1 in "Best Vitamins For Hair Growth" for Third Consecutive Year

Nutrafol Secures Multiple Top Honors from U.S. News & World Report, Including #1 in "Best Vitamins For Hair Growth" for Third Consecutive Year

Nutrafol has again been recognized by the experts in the 2026-2027 Best OTC Medicine & Health Products rankings, which U.S. News & World Report...

NUTRAFOL INTRODUCES MEN 50+, THE FIRST AND ONLY HAIR GROWTH PRODUCT SPECIFICALLY FORMULATED FOR MEN 50+

NUTRAFOL INTRODUCES MEN 50+, THE FIRST AND ONLY HAIR GROWTH PRODUCT SPECIFICALLY FORMULATED FOR MEN 50+

Nutrafol, the #1 dermatologist-recommended hair growth supplement brand[1] known for its bio-specific, whole-body approach, today announced the...

More Releases From This Source

Explore

Retail

Retail

Cosmetics and Personal Care

Cosmetics and Personal Care

Supplementary Medicine

Supplementary Medicine

Household, Consumer & Cosmetics

Household, Consumer & Cosmetics

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2026 Cision US Inc.